A discussion on whether adding a third antibiotic, targeted at the second, third, and fourth most abundant genera identified via next-generation sequencing (NGS), improves lung function recovery compared to standard dual intravenous therapy in Cystic Fibrosis patients with chronic Pseudomonas aeruginosa colonization.